PXAI
v8.42
Feed
Viral
World
Politics
Technology
Daily Briefing
Sources
|
ToS
Version History
Version
Description
Date
8.42
[ADDED SOURCE REGISTRY LIST VIEW]
04/03/2026 16:19
8.41
[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]
04/03/2026 16:11
8.40
[TRANSLATED FRONTEND TO US ENGLISH]
04/03/2026 16:10
8.41
[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]
04/03/2026 15:50
8.41
[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]
04/03/2026 15:46
8.40
[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]
04/03/2026 15:40
8.39
[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]
04/03/2026 15:38
8.38
[TRANSLATED SOURCES VIEW TO US ENGLISH]
04/03/2026 15:01
8.37
[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]
04/03/2026 14:58
8.67
[MANUAL OVERRIDE OF GREEK MENU ITEMS]
04/03/2026 13:36
8.66
[NGINX OPTIMIZED MENU FIX]
04/03/2026 13:33
8.65
[FIXED GREEK MENU ITEMS]
04/03/2026 13:32
8.60
[MENU & UI LOCALIZATION TO US ENGLISH]
04/03/2026 13:30
8.50
[FULL TRANSLATION TO US ENGLISH]
04/03/2026 13:27
9.75
[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]
26/02/2026 14:44
Best Buy (NYSE:BBY) Stock Price Expected to Rise, Evercore Analyst Says
Chronological Source Flow
Back
AI Fusion Summary
Analysts from Evercore, Mizuho, Oppenheimer, and Guggenheim raised their price targets for Best Buy, Ventas, Target, and Maze Therapeutics, signaling a positive outlook and expected stock price growth for these companies.
#stock market
#analyst upgrades
#price target
#Best Buy
#Target
#Ventas
#Maze Therapeutics
#equities research
06/03 09:24
defenseworld.net
5 Πηγές
Best Buy (NYSE:BBY) Stock Price Expected to Rise, Evercore Analyst Says
06/03 09:50
defenseworld.net
Ventas (NYSE:VTR) Stock Price Expected to Rise, Mizuho Analyst Says
06/03 10:52
defenseworld.net
Target (NYSE:TGT) Stock Price Expected to Rise, Oppenheimer Analyst Says
06/03 10:52
defenseworld.net
Target (NYSE:TGT) Stock Price Expected to Rise, Guggenheim Analyst Says
06/03 10:56
defenseworld.net
Maze Therapeutics (NASDAQ:MAZE) Stock Price Expected to Rise, Guggenheim Analyst Says
Comments
Loading...
Send
Dev Changelog
v8.42
No logs found in database.
0
Display Settings
Size
Aa
Brightness
Theme
Dark
Comments